Knowledge gaps about long-term osteoporosis drug therapy benefits, risks remain largeMay 1, 2019Women's Health
SRA737 + anti–PD-L1 therapy and low-dose gemcitabine shows early promise for SCLCApril 30, 2019Lung CancerImmuno-oncology
